Source link : https://newshealth.biz/health-news/glp-1-agonists-reduce-recurrent-atrial-fibrillation/
SAN DIEGO — Patients with obesity and diabetes are at a substantially reduced risk of having a recurrence of atrial fibrillation (AF) after ablation if they are taking a glucagon-like peptide 1 (GLP-1) receptor agonist vs another diabetes drug, according to an analysis of matched cohorts with 3 years of follow-up. The study was retrospective, […]
The post GLP-1 Agonists Reduce Recurrent Atrial Fibrillation first appeared on News Health.
—-
Author : News Health
Publish date : 2025-05-16 10:26:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8